🔬 MyoScreen™: The discovery platform redefining muscle disease research

bioprinting CYTOO
Why do human primary cells make all the difference? Unlike traditional cell lines, primary cells are directly isolated from human tissues. As a result, they retain donor-specific genetic traits and, when used as a multi-donor panel, reflect the genetic and phenotypic heterogeneity of the human population.

🎯 What makes MyoScreen™ unique:

→ Biobank of 65+ donors covering 10+ diseases (DMD, DM1, DM2, FSHD, Pompe, SMA, PMM…)

→ Optimized culture for primary myoblasts = maximum clinical relevance

→ Flexible metabolic disorder modeling

→ Custom donor sourcing on demand

→ Compatible with immortalized cell lines

 

đź’ˇ The goal? Accelerate therapy discovery by bridging the gap between lab and patient.

CYTOO combines proprietary biobanking expertise with access to samples through established partners, offering researchers unmatched flexibility.

 

🚀 Ready to power your next discovery with more predictive data?

đź“© Let’s discuss how MyoScreen™ can support your research program. Contact us today!

Share:

More Posts

Join us on LinkedIn

Contact us